Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978.
Hikma Pharmaceuticals PLC (LON:HIK) has announced that Siggi Olafsson has resigned as Chief Executive Officer, and from...
Hikma Pharmaceuticals PLC (LON:HIK), the multinational pharmaceutical company, has reported its interim results for the six months...
Hikma Pharmaceuticals PLC (LON:HIK), the multinational pharmaceutical company, has announced the approval of KLOXXADOTM (naloxone hydrochloride) nasal...
Hikma Pharmaceuticals PLC (LON:HIK), the multinational pharmaceutical company, has announced that it has resumed the launch of...
Data policy – All information should be used for indicative purposes only. You should independently check data before making any investment decision and or seek professional advice. DirectorsTalk cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.
You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.
